2 news items
Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors
SYRE
15 May 24
affairs at Amgen Inc.
"As a physician, Spyre's commitment to scientific excellence and patient
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
SYRE
9 May 24
Commitments
- Prev
- 1
- Next